YD Bio Ltd (YDES) News
Follow YD Bio Ltd (YDES) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
YDES reports unaudited financial results for six months ended June 30, 2026
YD Bio Limited (YDES) reports unaudited financial results for the six months ended June 30, 2026.
EQUITY | Aug 31, 2026, 10:07 PM UTC
L
YD Bio 1H EPS 9c, above YDES
YD Bio reports 1H EPS of 9c, above the YDES mark.
EARNINGS | Aug 31, 2026, 10:02 PM UTC
L
YD Bio 1H revenue $847,000
TradingView News reports YD Bio 1H revenue of $847,000.
EQUITY | Aug 31, 2026, 10:02 PM UTC
L
YD Bio (YDES) announces peer-reviewed Nutrients publication
YD Bio says a peer-reviewed publication in Nutrients was released, co-authored with physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute.
EQUITY | Aug 25, 2026, 12:02 PM UTC
L
YDES - YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration wit
YDES - YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Instit
GEOPOLITICS | Aug 11, 2026, 12:02 PM UTC
H
NXTS Plunges 48%
NXTS leads small cap negative movers premarket, down 48% on momentum, followed by WHLR, KIDZ, and others
EQUITY | Jun 23, 2026, 12:22 PM UTC